Heart drug duo under the microscope: can statins and SGLT2i work better together?

NCT ID NCT06520891

Recruiting now Disease control Sponsor: Fayoum University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 24 times

Summary

This study looks at whether combining two common heart medications—statins and SGLT2 inhibitors—can improve cholesterol levels and heart function in people with ischemic heart disease. Researchers will enroll 90 participants and measure drug levels in the blood along with lab tests. The goal is to see if the combination offers extra benefits for managing this chronic condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 2 DRUGS ARE STATIN AND SGLT2I are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asmaa mohamed abdelkader
RECRUITING

Al Fayyum, Faiyum Governorate, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

2 DRUGS ARE STATIN AND SGLT2I 2 DRUGS ARE STATIN AND SGLT2I